Home
Bluebird Bio

Bluebird Bio Market Share Analysis for November 2025

bluebird bio, Inc., based in Somerville, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders.

Health > Biotechnology and Pharmaceuticals

Domainbluebirdbio.com

Year Founded1992

Employees201 - 500

Annual Revenue$50M - $75M

Bluebird Bio

Bluebird Bio (including company regionals)

bluebirdbio.com

See more website traffic and engagement information

Bluebird Bio Revenue up to November 2025 is 50M - 75M

revenue generated by Bluebird Bio top domains

Bluebird Bio top domains revenue over 3 years

Revenue for Bluebird Bio top domains

bluebirdbio.com50M - 75M

See more with Sales Intelligence

Total visits to Bluebird Bio's top domains

Understand Bluebird Bio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

bluebirdbio.com5.7K

See more with Sales Intelligence

Avg. visit duration in Bluebird Bio's top domains

Analyze Bluebird Bio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

bluebirdbio.com00:00:27

See more with Sales Intelligence

Avg. pageviews on Bluebird Bio's top domains

See how Bluebird Bio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

bluebirdbio.com1.65

See more with Sales Intelligence

Bluebird Bio top competitors by domain

Top similar sites in November 2025, ranked by their affinity

agios.comCompany NameAgiosEmployees201 - 500HQUnited States, Massachusetts, CambridgeAnnual revenue$200M - $500MTotal visits15.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Bluebird Bio

These are the website technologies, by industry, used by Bluebird Bio top domains

Email Services (6)

Sendgrid

Content Management System (4)

WordPress

Conversion & Analytics (4)

Google Analytics

Social (4)

Google+ Platform

More Technologies

11

See all

News & Signals from Bluebird Bio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBluebird Bio, Inc acquired carlyle for $0 on Feb 21st '25.bluebird bio announced on 21 February 2025 that it had entered into a definitive agreement to be acquired global investment firms Carlyle (DC, USA) and SK Capital (NY, USA) for US$3.00 per share in cash, plus a contingent value right of $6.84 per share if certain sales targets are met.

NewsBluebird Bio, Inc decreased headcount by 94 on Sep 1st '24.Last September, Bluebird implemented a restructuring that cut 94 employees, representing about 25% of its workforce.

NewsBluebird Bio, Inc sells assets to SK Capital Partners, LP in the amount of $30M.Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million.